Company intelligence / Profile preview

Genpharm Services

Dubai, United Arab Emirates

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Genpharm enables commercial distribution and rapid market access for rare disease and specialty care medicines in the MENAT region. It has pioneered launch of gene therapies and commercialized products such as setmelanotide (IMCIVREE) and migalastat for Fabry disease in Middle East/GCC via regional exclusive agreements with global innovators.[6][4][5]

Therapeutic areas: EndocrinologyRare Diseases
Modalities: Gene therapySmall moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Novartis Gene TherapyOrchard TherapeuticsPTC TherapeuticsSarepta TherapeuticsUltragenyx PharmaceuticalsBiohaven PharmaceuticalsargenxAmicus TherapeuticsApellis PharmaceuticalsRhythm Pharmaceuticals

Beyond the preview

Go deeper on Genpharm Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genpharm Services.

Explore the full profile